JAKARTA, INDONESIA--(Marketwire - Nov 5, 2012) - Moments ago, TradersInsight.net introduced new coverage of Hologic, Inc. (
The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include a rise in new home sales to 5.7% in September to an annualized pace of 389,000 units, slightly stronger than market expectations for an increase to 385,000, recent confirmation of continued monetary stimulus and an unchanged FOMC policy and recent moderation of existing home sales in the US to 4.75 million annualized units in September 2012 from 4.83 million reported in the previous month. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox.
Traders Insight is releasing new coverage on Hologic, Inc. for its current position within the health care sector. Hologic, Inc. is a developer, manufacturer and supplier of diagnostics, medical imaging systems and surgical products for the healthcare needs of women. The Company's business segments are focused on breast health, diagnostics, GYN surgical and skeletal health. A copy of this report featuring Hologic, Inc. (
Traders Insight has released research on CareFusion Corporation for its changing role within the health care sector. CareFusion Corporation is a global medical technology company. To access the full research report on CareFusion Corporation (
About Traders Insight
Find direction and insight with TradersInsight.net. Our model of enabling open collaboration between members is breaking new ground into the investment community. By tapping into the resources of the community, we are crowd-sourcing our reach. As a result - we have been able to identify some of the greatest moving companies on the market today. The evidence is in the results, join today and experience what you've been missing.